Drug Type Small molecule drug |
Synonyms ZSP 1241, ZSP-1241 |
Target |
Action antagonists |
Mechanism FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 13 Nov 2018 | |
Bile Duct Neoplasms | Phase 1 | China | 13 Nov 2018 | |
Colorectal Cancer | Phase 1 | China | 13 Nov 2018 | |
Esophageal Carcinoma | Phase 1 | China | 13 Nov 2018 | |
Hepatocellular Carcinoma | Phase 1 | China | 13 Nov 2018 | |
Stomach Cancer | Phase 1 | China | 13 Nov 2018 |